CATALINA-4: PHASE 1B/2 STUDY OF TORL-1-23 WITH NEOADJUVANT CHEMOTHERAPY AND INTERVAL CYTOREDUCTIVE SURGERY IN NEWLY DIAGNOSED PATIENTS WITH ADVANCED STAGE OVARIAN CANCER